Article
Double Duty: Complete Pathologic Response of Two Colonic Primaries with Mosaicism of a Novel MLH1 Mutation to Neoadjuvant Pembrolizumab.
Current oncology (Toronto, Ont.) - 6 Oct 2023
Preti Beatrice, Schenkel Laila, Cecchini Matthew, Romagnoli Tommaso, Sanatani Michael Susmoy, French Karissa, Colquhoun Patrick, Vincent Mark David
Abstract excerpt
We present a fascinating case of a 57-year-old male with a novel mutation in MLH1 (MLH1:c.1288G > T, p.(Glu430*)), who presented with two synchronous colonic tumours, initially deemed unresectable, and experienced a complete pathological response on neoadjuvant pembrolizumab. Extensive genetic testing revealed post-zygotic mosaicism from the novel mutation.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
